跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLYBURIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GLYBURIDE
Authorized
STANDARD
GLYBURIDE
PRO DOC LIMITEE
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4981b67c4dfdf60c
Company
PRO DOC LIMITEE
Type
Standard
Approval Details
Approval Id
4981b67c4dfdf60c
Drug Approval Canada Name
GLYBURIDE
Product Name
GLYBURIDE
Status
Cancelled Post Market
Status Date
2024-06-17
Original Market Date
2019-02-27
Din
02485664
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.20
Atc Original
A10BB01 GLIBENCLAMIDE
Atc Name
a 10 bb 01
Aig Number
0108708001
Company Name
PRO DOC LIMITEE
Company Address
2925 Boulevard Industriel, Laval, Quebec, Canada, H7L 3W9
Active Ingredients
GLYBURIDE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4981b67c4dfdf60c
Type
Standard
Back to Health Canada Approvals